【Topic】Business Models and Valuation in Biotech Companies

【Speaker】Todd Morrill, Instructor at the Haas School of Business at UC Berkeley

【Time】2007-5-16 14:00-15:30

【Venue】Room 404, Weilun Building

【Language】English

【Organizer】Department of Entrepreneur and Innovation, Tsinghua Science Park

【Target Audience】Faculty, students and business professionals

【Background Information】

T. Todd Morrill

Todd manages Acquisitions, Business Development and Strategic Research for the Life Sciences Group at Bio-Rad Laboratories, a $1.3 billion manufacturer of biopharmaceutical research instrumentation, assays and clinical diagnostics. Todd and his team are responsible for Groupstrategy, acquisitions, business development and exploratory research; they identify, negotiate, and close opportunities across Bio-Rad’s broad proteomics, genomics, food science, and protein function interests. Todd also works closely with the operating Divisions and international subsidiaries to implement portfolio management and strategic directives, and to access technology globally.Recently, he led the teams integrating MJ Research, Proteomeweaver, ProteOptics and Ciphergen into Bio-Rad globally.

In addition to his ‘day job’, Todd is an instructor at the Haas School of Business at UC Berkeley, where he teaches ‘Entrepreneurship in Biotechnology’ and courses in the Executive Program.These graduate-level courses brings scientists, engineers, and business students together to better understand the ‘concept to company’ process in biotech and medical devices.The courses are sponsored by theLesterCenterfor Entrepreneurship, the Berkeley Executive Education program,and the Management of Technology program at Haas, theSchoolofEngineering, and Molecular and Cell Biology, UC Berkeley.